Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Nasdaq Biotechnology Ishares ETF (IBB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund basics

See More
  • Fund Family BlackRock
  • Assets Under Management 9,197,921,600
  • Shares Outstanding, K 79,850
  • Annual Dividend & Yield 0.40 (0.35%)
  • Price/Earnings ttm 19.97
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
113.90 +2.19%
on 07/30/18
120.06 -3.06%
on 07/24/18
-1.10 (-0.94%)
since 07/16/18
3-Month
105.85 +9.96%
on 05/29/18
120.06 -3.06%
on 07/24/18
+8.86 (+8.24%)
since 05/16/18
52-Week
100.22 +16.13%
on 04/06/18
120.06 -3.06%
on 07/24/18
+13.03 (+12.61%)
since 08/16/17

Most Recent Stories

More News
Health Care ETFs Outperforming: Will the Rally Last?

Health care ETFs are defensive ones, which helped those to shine amid market doldrums.

XLU : 54.25 (+1.10%)
XPH : 48.61 (+1.08%)
XLV : 90.81 (+0.98%)
XLY : 112.47 (+0.55%)
IBB : 116.30 (+0.80%)
IHI : 209.53 (+0.68%)
XLP : 54.64 (+1.50%)
Health Care ETFs Outperforming: Will the Rally Last?

Health care ETFs are defensive ones, which helped those to shine amid market doldrums.

XLU : 54.25 (+1.10%)
XPH : 48.61 (+1.08%)
XLV : 90.81 (+0.98%)
XLY : 112.47 (+0.55%)
IBB : 116.30 (+0.80%)
IHI : 209.53 (+0.68%)
XLP : 54.64 (+1.50%)
Biotech ETFs in Focus on String of Q2 Earnings Beat

Biotech ETFs draw attention post impressive Q2 results.

IBB : 116.30 (+0.80%)
FBT : 149.78 (+1.08%)
BBH : 129.44 (+1.08%)
IEIH : 26.35 (+1.62%)
GILD : 75.42 (+0.77%)
AMGN : 196.74 (+0.76%)
ALXN : 116.96 (+1.42%)
BIIB : 343.10 (+0.70%)
Biotech ETFs in Focus on String of Q2 Earnings Beat

Biotech ETFs draw attention post impressive Q2 results.

IBB : 116.30 (+0.80%)
FBT : 149.78 (+1.08%)
BBH : 129.44 (+1.08%)
IEIH : 26.35 (+1.62%)
GILD : 75.42 (+0.77%)
AMGN : 196.74 (+0.76%)
ALXN : 116.96 (+1.42%)
BIIB : 343.10 (+0.70%)
What Investors Need to Know about Biotech ETFs

Smaller biotech stocks are outperforming this year; learn more about biotech ETFs best positioned to benefit

IBB : 116.30 (+0.80%)
FBT : 149.78 (+1.08%)
XBI : 93.83 (+0.81%)
What Investors Need to Know about Biotech ETFs

Smaller biotech stocks are outperforming this year; learn more about biotech ETFs best positioned to benefit

IBB : 116.30 (+0.80%)
FBT : 149.78 (+1.08%)
XBI : 93.83 (+0.81%)
Biotech ETFs Surge on Biogen's Positive Drug Trial Result

Biotech ETFs surge on Biogen's encouraging Phase 2 clinical study data for Alzheimer???s treatment.

PBE : 57.71 (+1.00%)
CELG : 90.17 (+1.01%)
IBB : 116.30 (+0.80%)
FBT : 149.78 (+1.08%)
BBH : 129.44 (+1.08%)
GILD : 75.42 (+0.77%)
AMGN : 196.74 (+0.76%)
BIIB : 343.10 (+0.70%)
Biotech ETFs Surge on Biogen's Positive Drug Trial Result

Biotech ETFs surge on Biogen's encouraging Phase 2 clinical study data for Alzheimer???s treatment.

PBE : 57.71 (+1.00%)
CELG : 90.17 (+1.01%)
IBB : 116.30 (+0.80%)
FBT : 149.78 (+1.08%)
BBH : 129.44 (+1.08%)
GILD : 75.42 (+0.77%)
AMGN : 196.74 (+0.76%)
BIIB : 343.10 (+0.70%)
Why Biotech Stocks Rallied on Biogen's Alzheimer's Test

Several major biotech stocks rallied on Friday after Biogen (BIIB) reported positive results from a Phase 2 study of its Ban2401 therapy, which seeks to reduce toxic amyloid proteins associated with cognitive...

CELG : 90.17 (+1.01%)
ESALY : 88.4900 (+0.56%)
IBB : 116.30 (+0.80%)
GILD : 75.42 (+0.77%)
AMGN : 196.74 (+0.76%)
BIIB : 343.10 (+0.70%)
Sarepta Pharma Pushes Two Biotech ETFs to New Highs

The encouraging early trial results for a gene therapy for Duchenne muscular dystrophy pushed Sarepta Therapeutics and few biotech ETFs to new highs.

BBP : 43.20 (+0.91%)
SLDB : 38.71 (+0.60%)
BBC : 32.35 (+1.13%)
SBIO : 37.25 (+0.87%)
SRPT : 128.78 (+2.43%)
IBB : 116.30 (+0.80%)
VRTX : 175.14 (+1.24%)
ALNY : 92.52 (+1.43%)
XBI : 93.83 (+0.81%)
ALXN : 116.96 (+1.42%)
BIIB : 343.10 (+0.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade IBB with:

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

2nd Resistance Point 117.38
1st Resistance Point 116.38
Last Price 116.30
1st Support Level 114.69
2nd Support Level 114.00

See More

52-Week High 120.06
Last Price 116.30
Fibonacci 61.8% 112.48
Fibonacci 50% 110.14
Fibonacci 38.2% 107.80
52-Week Low 100.22

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar